Stock Evaluator: West Pharmaceutical Services, Inc. (WST)

West Pharmaceutical Services, Inc. WST

$340.96 1.37 0.40%
July 31, 2026 4:00:03 PM EST November 10, 2021 Volume: 1,047,407
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Life Sciences Tools & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Commentary & Analysis


Financial Summary

Share Statistics WST Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $23,995.3 $1,790.4 88%
Shares Out (Mil) 71.3 94.8 56%
Institutional Ownership 99.4% 90.0% 88%
Float (Mil) 69.9 69.9 55%
Beta 1.16 1.20 68%
Avg Daily Volume (000s) 1,058 814 71%
Price Change
(52-week)
36.8% 80.2% 73%
Growth WST Industry
Median
Percentile
(All Stocks)
Sales (5yr) 7.4% 7.8% 48%
Net Income (5yr) 7.4% (13.7%) 51%
EPS (5yr) 8.2% 0.7% 43
Dividends (5yr) 5.5% 0.0% 77%
Cash Flow (5yr) 12.1% (15.0%) 71%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 12 16 16
Current EPS $2.182 $8.936 $9.938
Month Ago EPS $2.125 $8.610 $9.557
# Rev Up 0 1 0
# Rev Down 1 0 1
Three Months Ago EPS $2.134 $8.620 $9.553
Year/Year Chg 1.5% 31.6% 66.2%
Financials WST Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $3,327 $785 69%
Net Income (TTM) (Mil) $565 ($14) 80%
EPS (TTM) $7.862 ($0.200) 92%
Operating Cash Flow (TTM) (Mil) $662 $53 75%
Net Cash Flow (TTM) (Mil) ($74) ($4) 16%
Long-Term Debt (Q1) (Mil) $294 $270 54%
Enterprise Value (Q1) (Mil) $22,978 $2,444 85%
Valuation WST Industry
Median
Percentile
(All Stocks)
P/B 8.03 2.92 87%
P/E 43.7 43.7 81%
Dividend Yield 0.3% 0.0% 61%
PEG (5yr hist) 5.3 5.3 88%
Ratios WST Industry
Median
Percentile
(All Stocks)
Gross Margin 36.8% 47.6% 45%
Net Margin 17.0% (2.9%) 76%
ROA 14.1% (2.8%) 93%
ROE 19.1% (4.5%) 78%
Liabilities to Assets 26.6% 43.0% 18%
F-Score 9 5 99%

West Pharmaceutical Services, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors